Cognos’ SINNAIS Smart Implantable Pump to Improve CAR T Cell Efficacy in Solid tumors

Cognos Therapeutics believes its SINNAIS implantable pump can increase efficacy of CAR T therapies for the treatment of leukemia.

Cognos Therapeutics plans to conduct a twenty-patient human clinical trial using direct delivery of Herceptin (a Genentech drug) to prove drug safety in the brain region.

Cognos Therapeutics plans to conduct a 20-patient human clinical trial for direct delivery of Herceptin using the Sinnais implantable pump.

Dr. Francis Ali-Osman

Dr. Francis Ali-Osman speaks at the Hancock Symposium at Westminster Collage on the state of cancer research and treatment.

FDA’s Role In The Precision Medicine Initiative Pushes Combination Drug Devices to New Heights Sharing Cognos Therapeutics Vision.

Cognos Therapeutics’ Sinnais drug delivery technology is poised to meet the need for Companion Diagnostic modalities.

NEWS and INFORMATION

The following posts and articles are for information only regarding advancements in our technology and business as well as relevant articles on the state of research and important voices of authority in the medical community.

Dr. Francis Ali-Osman

Dr. Francis Ali-Osman

Dr. Francis Ali-Osman speaks at the Hancock Symposium at Westminster Collage on the state of cancer research and treatment.

read more